Smith Robert Paul JR
SEC CIK 2003059 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GOSS | Gossamer Bio, Inc. | Chief Commercial Off | 260.9K | $15.0K | — | 3 | 2024-06-17 | 2026-01-02 |
Most active insiders at GOSS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Smith Robert Paul JR | Chief Commercial Off | — | — |
| 2 | Aranda Richard | Chief Medical Off | — | — |
| 3 | Peterson Caryn | EVP, Regulatory Affairs | — | — |
| 4 | Giraudo Bryan | COO, CFO | — | — |
| 5 | Christian Waage | EVP, Tech Ops, Admin | — | — |
| 6 | Hasnain Faheem | Pres, CEO, Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2026-01-02 | GOSS | Gossamer Bio, Inc. | Smith Robert Paul JR | Chief Commercial Off | A - Grant | $0.00 | +93.8K | 260.9K | +56% | $0 |
| 2025-10-02 | 2025-10-01 | GOSS | Gossamer Bio, Inc. | Smith Robert Paul JR | Chief Commercial Off | A - Grant | $0.00 | +162.5K | 162.5K | New | $0 | |
| I | 2024-06-20 | 2024-06-17 | GOSS | Gossamer Bio, Inc. | Smith Robert Paul JR | Chief Commercial Off | P - Purchase | $0.6 | +25.0K | 25.0K | New | +$15.0K |
Purchase Sale Sale after option exercise All abbreviations